We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

64 hedge funds and large institutions have $44.7M invested in Filana Therapeutics in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 28 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 66 → 64 (-2)

8% less capital invested

Capital invested by funds: $48.4M → $44.7M (-$3.72M)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

61% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 28

Holders
64
Holders Change
-2
Holders Change %
-3.03%
% of All Funds
1.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
28
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$877K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$114K
3
State Street
State Street
Massachusetts
+$82.7K
4
Renaissance Technologies
Renaissance Technologies
New York
+$66.1K
5
BIT
BlackRock Institutional Trust
California
+$40.1K

Top Sellers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
-$235K
2
Millennium Management
Millennium Management
New York
-$189K
3
PGCM
Prescott Group Capital Management
Oklahoma
-$187K
4
Morgan Stanley
Morgan Stanley
New York
-$173K
5
GCP
GSA Capital Partners
United Kingdom
-$150K
Name Holding Trade Value Shares
Change 		Change in
Stake
First Eagle Investment Management
1
First Eagle Investment Management
New York
$10.7M – – –
VAM
2
Visium Asset Management
New York
$8.22M -$94 -7 -0%
NCM
3
Nantahala Capital Management
Connecticut
$4.14M +$877K +64,987 +26%
BIT
4
BlackRock Institutional Trust
California
$3.01M +$40.1K +2,974 +1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.57M +$114K +8,412 +5%
BFA
6
BlackRock Fund Advisors
California
$1.98M -$16.1K -1,195 -0.8%
Deutsche Bank
7
Deutsche Bank
Germany
$1.89M -$148 -11 -0%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$1.46M – – –
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$1.21M -$116K -8,628 -9%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$916K -$20.5K -1,518 -2%
Northern Trust
11
Northern Trust
Illinois
$807K -$2.23K -165 -0.3%
MERSOM
12
Municipal Employees' Retirement System of Michigan
Michigan
$803K – – –
State Street
13
State Street
Massachusetts
$783K +$82.7K +6,132 +12%
GIM
14
Granahan Investment Management
Massachusetts
$654K +$4.67K +346 +0.7%
Renaissance Technologies
15
Renaissance Technologies
New York
$640K +$66.1K +4,900 +11%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$511K +$675 +50 +0.1%
BCM
17
Bridgeway Capital Management
Texas
$454K -$235K -17,443 -34%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$422K +$9.49K +703 +2%
GF
19
Gabelli Funds
New York
$312K -$19.3K -1,429 -6%
6CM
20
683 Capital Management
New York
$262K – – –
TCIM
21
TIAA CREF Investment Management
New York
$249K – – –
BIM
22
BlackRock Investment Management
Delaware
$218K +$9.61K +712 +5%
GCP
23
GSA Capital Partners
United Kingdom
$211K -$150K -11,150 -41%
TA
24
Teton Advisors
New York
$210K – – –
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$201K – – –
1
2 3

FLNA Hedge Fund Activity: Q1 2015 in Review

64 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2015, worth a combined $44.7M — down 7.7% from $48.4M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of FLNA and 7 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 11 added.

The largest buyer was Nantahala Capital Management, adding an estimated $877K. The largest seller was Bridgeway Capital Management, cutting an estimated $235K.

  • 64 institutional investors held Filana Therapeutics (FLNA) as of Q1 2015, down from 66 in Q4 2014.
  • Funds reported $44.7M of Filana Therapeutics stock for Q1 2015, down 7.7% quarter-over-quarter.
  • 7 funds opened new Filana Therapeutics positions in Q1 2015 and 8 closed out, a net change of -1 holder.
  • The largest Filana Therapeutics buyer in Q1 2015 was Nantahala Capital Management, an estimated $877K added.
  • The largest Filana Therapeutics seller in Q1 2015 was Bridgeway Capital Management, an estimated $235K sold.

Based on aggregated 13F filings for Q1 2015.